Setting Standards for Proactive Pharmacovigilance in India
With more clinical research being conducted India, there is growing pressure to address pharmacovigilance concerns. Dr. Seema Rajsingh, Head- Pharmacovigilance at Biocon, joins Andrea Charles from Pharma IQ, to discuss the main challenges the industry currently faces, setting the standards for proactive pharmacovigilance in India and the strategies Indian pharmaceutical companies are employing to optimise their drug safety teams and pharmacovigilance activities.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.